UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 87

Sortiert nach

Use of anakinra in severe COVID-19: A case report

International journal of infectious diseases, 2020-07, Vol.96, p.607-609

2020

Volltextzugriff (PDF)

Macrophage Activation Syndrome

Hematology/oncology clinics of North America, 2015-10, Vol.29 (5), p.927-941

2015

Volltextzugriff (PDF)

Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report

Frontiers in immunology, 2023-12, Vol.14, p.1288675-1288675

2023

Volltextzugriff (PDF)

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis

Frontiers in pharmacology, 2016-12, Vol.7, p.467-467

2016

Volltextzugriff (PDF)

Clinical features and correct diagnosis of macrophage activation syndrome

Expert review of clinical immunology, 2015-09, Vol.11 (9), p.1043-1053

2015

Volltextzugriff (PDF)

COVID-19 multidisciplinary high dependency unit: the Milan model

Respiratory research, 2020-10, Vol.21 (1), p.260-260, Article 260

2020

Volltextzugriff (PDF)

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Pediatric rheumatology online journal, 2020-07, Vol.18 (1), p.56-56, Article 56

2020

Volltextzugriff (PDF)

Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

ACR open rheumatology, 2019-08, Vol.1 (6), p.345-349

2019

Volltextzugriff (PDF)

CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever

Frontiers in immunology, 2018-01, Vol.8, p.2015-2015

2018

Volltextzugriff (PDF)

Acute Retinal Necrosis: Clinical Features, Diagnostic Pitfalls, Treatment, and Outcome of an Insidious Disease in Children. Case Report and Review of the Literature

Frontiers in pediatrics, 2022-04, Vol.10, p.854325

2022

Volltextzugriff (PDF)

Correction to: Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature

Pediatric rheumatology online journal, 2021-07, Vol.19 (1), p.115-115, Article 115

2021

Volltextzugriff (PDF)

Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report

Frontiers in pediatrics, 2023-06, Vol.11, p.1175584

2023

Volltextzugriff (PDF)

Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature

Pediatric rheumatology online journal, 2021-06, Vol.19 (1), p.80-80, Article 80

2021

Volltextzugriff (PDF)

Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey

Frontiers in pediatrics, 2022-11, Vol.10, p.1030083-1030083

2022

Volltextzugriff (PDF)

Infection-Triggered Hyperinflammatory Syndromes in Children

Children (Basel), 2022-04, Vol.9 (4), p.564

2022

Volltextzugriff (PDF)

Biologics in juvenile idiopathic arthritis: a narrative review

European journal of pediatrics, 2017-09, Vol.176 (9), p.1147-1153

2017

Volltextzugriff (PDF)

Filling the Gap: Toward a Disease Activity Tool for Systemic Juvenile Idiopathic Arthritis

Journal of rheumatology, 2018-01, Vol.45 (1), p.3

2018

Volltextzugriff (PDF)

Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Annals of the rheumatic diseases, 2019-10, Vol.78 (10), p.1357

2019

Volltextzugriff (PDF)

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Arthritis & rheumatology (Hoboken, N.J.), 2014-11, Vol.66 (11), p.3160-3169

2014

Volltextzugriff (PDF)

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis

Arthritis care & research (2010), 2018-03, Vol.70 (3), p.409-419

2018

Volltextzugriff (PDF)

Development and Preliminary Validation of an Electromyography-Scoring Protocol for the Assessment and Grading of Muscle Involvement in Patients With Juvenile Idiopathic Inflammatory Myopathies

Pediatric neurology, 2021-11, Vol.124, p.6-10

2021

Volltextzugriff (PDF)

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey

Pediatric rheumatology online journal, 2021-03, Vol.19 (1), p.29-29, Article 29

2021

Volltextzugriff (PDF)

Cytokine storm syndrome in a young patient with cystic fibrosis

Pediatric pulmonology, 2021-10, Vol.56 (10), p.3435-3437

2021

Volltextzugriff (PDF)

When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease

Clinical immunology (Orlando, Fla.), 2019-08, Vol.205, p.25-28

2019

Volltextzugriff (PDF)

1 – 25 von 87

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(75)

Publikationsform

Sprache

Englisch
(87)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Life Sciences & Biomedicine
(59)
Humans
(37)
Rheumatology
(21)
Female
(20)
Male
(18)
Child
(16)
Pediatrics
(14)
Patients
(12)
Macrophage Activation Syndrome
(10)
Laboratories
(9)
Retrospective Studies
(9)
Arthritis
(8)
Systemic Juvenile Idiopathic Arthritis
(8)
Arthritis, Juvenile - Complications
(7)
Child, Preschool
(7)
Hemophagocytic Lymphohistiocytosis
(7)
Middle Aged
(7)
Oncology
(7)
Aged
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Use of anakinra in severe COVID-19: A case report

Macrophage Activation Syndrome

Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report

IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis

Clinical features and correct diagnosis of macrophage activation syndrome

COVID-19 multidisciplinary high dependency unit: the Milan model

Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases

Ferritin to Erythrocyte Sedimentation Rate Ratio: Simple Measure to Identify Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis

CD70 Deficiency due to a Novel Mutation in a Patient with Severe Chronic EBV Infection Presenting As a Periodic Fever

Acute Retinal Necrosis: Clinical Features, Diagnostic Pitfalls, Treatment, and Outcome of an Insidious Disease in Children. Case Report and Review of the Literature

Correction to: Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature

Can early-onset acquired demyelinating syndrome (ADS) hide pediatric Behcet's disease? A case report

Juvenile idiopathic arthritis in Harlequin ichthyosis, a rare combination or the clinical spectrum of the disease? Report of a child treated with etanercept and review of the literature

Approaches to SARS-CoV-2 and other vaccinations in children with a history of multisystem inflammatory syndrome (MIS-C): An international survey

Infection-Triggered Hyperinflammatory Syndromes in Children

2016 Classification Criteria for Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis

Biologics in juvenile idiopathic arthritis: a narrative review

Filling the Gap: Toward a Disease Activity Tool for Systemic Juvenile Idiopathic Arthritis

Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis

Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients

Effect of Biologic Therapy on Clinical and Laboratory Features of Macrophage Activation Syndrome Associated With Systemic Juvenile Idiopathic Arthritis

Development and Preliminary Validation of an Electromyography-Scoring Protocol for the Assessment and Grading of Muscle Involvement in Patients With Juvenile Idiopathic Inflammatory Myopathies

Defining Kawasaki disease and pediatric inflammatory multisystem syndrome-temporally associated to SARS-CoV-2 infection during SARS-CoV-2 epidemic in Italy: results from a national, multicenter survey

Cytokine storm syndrome in a young patient with cystic fibrosis

When neonatal inflammation does not mean infection: an early-onset mevalonate kinase deficiency with interstitial lung disease

Suchergebnisse filtern